PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
-15.12%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$96.6M
AUM Growth
+$96.6M
(-21%)
Cap. Flow
-$19.4M
Cap. Flow
% of AUM
-20.06%
Top 10 Holdings %
Top 10 Hldgs %
32.65%
Holding
115
New
5
Increased
36
Reduced
27
Closed
10
Top Buys
| 1 |
Magnite
MGNI
|
$999K |
| 2 |
Fortress Biotech
FBIO
|
$553K |
| 3 |
NeoGenomics
NEO
|
$408K |
| 4 |
SRXH
SRX Health Solutions, Inc.
SRXH
|
$379K |
| 5 |
Gryphon Digital Mining
GRYP
|
$300K |
Top Sells
| 1 |
BIOL
Biolase, Inc.
BIOL
|
$13.5M |
| 2 |
Rockwell Medical
RMTI
|
$4.87M |
| 3 |
ATRS
Antares Pharma, Inc.
ATRS
|
$1.97M |
| 4 |
LeMaitre Vascular
LMAT
|
$1.95M |
| 5 |
International Flavors & Fragrances
IFF
|
$563K |
Sector Composition
| 1 | Healthcare | 54.27% |
| 2 | Technology | 19.35% |
| 3 | Communication Services | 8.2% |
| 4 | Consumer Staples | 7.18% |
| 5 | Industrials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $4.35M | 4.5% | 13,408 | – | – |
|
2
Microsoft
MSFT
$3.77T
| $3.98M | 4.12% | 15,493 | – | – |
|
3
Idexx Laboratories
IDXX
$51.8B
| $3.79M | 3.92% | 10,805 | – | – |
|
4
Abbott
ABT
$231B
| $2.94M | 3.05% | 27,080 | – | – |
|
5
OptimizeRx
OPRX
$335M
| $2.94M | 3.04% | 107,230 -100 | -0.1% | -$2.74K |
|
6
Inuvo
INUV
$49.5M
| $2.88M | 2.98% | 5,812,672 +7,640 | +0.1% | +$3.78K |
|
7
Digi International
DGII
$1.29B
| $2.83M | 2.93% | 116,850 -600 | -0.5% | -$14.5K |
|
8
Pfizer
PFE
$141B
| $2.78M | 2.88% | 53,023 -250 | -0.5% | -$13.1K |
|
9
Veracyte
VCYT
$2.39B
| $2.55M | 2.64% | 128,130 +5,150 | +4% | +$102K |
|
10
Axogen
AXGN
$743M
| $2.51M | 2.59% | 305,940 +17,750 | +6% | +$145K |
|
11
Natera
NTRA
$23.1B
| $2.29M | 2.37% | 64,700 +6,300 | +11% | +$223K |
|
|
PFIE
12
DELISTED
Profire Energy, Inc
PFIE
| $2.24M | 2.32% | 1,554,380 -3,565 | -0.2% | -$5.13K |
|
13
QuickLogic
QUIK
$84.3M
| $2.12M | 2.2% | 250,285 +3,503 | +1% | +$29.7K |
|
|
STRM
14
DELISTED
Streamline Health Solutions
STRM
| $2.11M | 2.18% | 1,658,140 +990 | +0.1% | +$1.26K |
|
15
Advanced Micro Devices
AMD
$264B
| $2M | 2.07% | 26,184 | – | – |
|
16
Perion Network
PERI
$416M
| $1.88M | 1.95% | 103,351 -3,300 | -3% | -$60K |
|
|
SRXH
17
SRX Health Solutions, Inc.
SRXH
$13.9M
| $1.85M | 1.92% | 842,250 +172,250 | +26% | +$379K |
|
18
AbbVie
ABBV
$372B
| $1.84M | 1.91% | 12,025 | – | – |
|
19
Ooma
OOMA
$356M
| $1.77M | 1.83% | 149,675 -750 | -0.5% | -$8.88K |
|
|
20
NeoGenomics
NEO
$1.13B
| $1.65M | 1.71% | 202,550 +50,000 | +33% | +$408K |
|
21
Elutia
ELUT
$96.7M
| $1.6M | 1.66% | 226,729 -1,000 | -0.4% | -$7.07K |
|
22
General Mills
GIS
$26.4B
| $1.6M | 1.65% | 21,175 -175 | -0.8% | -$13.2K |
|
23
Cantaloupe
CTLP
$797M
| $1.51M | 1.57% | 270,125 +12,000 | +5% | +$67.2K |
|
24
AtriCure
ATRC
$1.84B
| $1.4M | 1.45% | 34,350 | – | – |
|
25
Exagen
XGN
$217M
| $1.36M | 1.41% | 236,975 +36,000 | +18% | +$207K |
|